Introduction
Substantially improved oncological treatment strategies have decreased childhood cancer mortality (Smith et al., 2014) . These treatments use effective radio-or chemotherapy, which destroy mitotically active tumor cells. Unfortunately, as a side effect, the spermatogonial population, which forms the basis for spermatogenesis, is also affected (Ginsberg, 2011) . Depending on treatment dose and fractionation, oncological treatments result in temporary or permanent infertility, affecting the quality of life of these patients (Jahnukainen et al., 2011) . Gonadotoxicity also accompanies treatment of non-malignant hematological diseases such as thalassemia. In addition, 47, XXY Klinefelter syndrome (KS) boys are confronted with the depletion or even the loss of germ cells during development (Wikström et al., 2004) . KS is the most common sex chromosomal disorder with a prevalence of 0.2% in the male population (Nieschlag et al., 2016) . It was estimated that only~25% of men with KS are identified during their lifetime (Bojesen et al., 2003) , but the number of children diagnosed prenatally with KS is increasing due to noninvasive prenatal testing (SamangoSprouse et al., 2017) . In these three patient groups, fertility preservation has therefore become increasingly important (Smith et al., 2014) . In postpubertal males, fertility preservation can be achieved by cryopreservation of sperm prior to treatment which can later be used for IVF (Kamischke et al., 2005) . In prepubertal patients, however, storage of sperm cannot be offered as the spermatogonia have not yet completed differentiation into spermatozoa. Infertility risk therefore particularly constitutes a burden for prepubertal male patients who have only undifferentiated germ cells.
Aimed at providing these patients with the opportunity to father own children later in life, specialized centers worldwide have started to offer cryopreservation of immature testicular tissues (Picton et al., 2015) . Cryopreservation is offered although there are currently no protocols available to use immature spermatogonia for derivation of sperm in vitro or for restoral of fertility in patients by autologous germ cell transplantation. To assess whether germ cell maturation can be achieved from such preserved tissues, first clinics consider starting re-transplantation. It is important to note, however, that the fertility preservation potential of individual cryopreserved samples will be highly variable depending on disease or pretreatment of respective patients, resulting in a highly heterogeneous patient cohort with regard to the state of the testicular tissue (VanSaen et al., 2015) . A lack of standardized parameters for the diagnostic characterization of such tissues therefore presents a clinical need that is clearly unmet. Moreover, standardized parameters will also be of great value for experimental approaches including re-transplantation of spermatogonial stem cells (SSCs) into the testis, grafting or in vitro differentiation of spermatogonia into sperm. Feasibility of these approaches has been demonstrated using animal models, including primates. Reestablishment of spermatogenesis after busulfan treatment was possible following autotransplantation of primate testicular cells (Hermann et al., 2012) . Also, autologous grafting of primate testicular tissues resulted in the production of sperm (Luetjens et al., 2008; Jahnukainen et al., 2012) . Furthermore, feasibility of in vitro spermatogenesis was experimentally shown by employing an organ culture approach. Sato et al. (2011) demonstrated the derivation of sperm from neonatal mouse testicular tissues. While this approach has also been successfully transferred to the rat (Reda et al., 2016) , human in vitro spermatogenesis has not yet been achieved (de Michele et al., 2016) . Reasons for this most likely include the fundamental differences between rodents and humans regarding the SSC system .
Our study aimed at establishing parameters for the histological characterization of immature human testicular tissues, hypothesizing that testicular tissue composition, absolute germ cell numbers and germ cell differentiation status should be highly variable in stored testicular tissues. Samples were obtained from a patient cohort who stored testicular tissues as a fertility reserve at our center (Kliesch, 2016) . Based on our results, we have proposed a diagnostic germ cell score. This score should enable individualized patient counseling regarding the potential of their cryopreserved testicular tissues as a fertility reserve. In addition, this score will ensure comparability of results obtained from experimental in vitro spermatogenesis, re-transplantation and tissue grafting trials in centers worldwide. Human testicular tissues biopsy procedure and tissue preparation Testicular biopsies of 39 patients (Table I) were collected at the Centre of Reproductive Medicine and Andrology in Münster, Germany, in the framework of the German fertility preservation program 'Androprotect'. Written informed consent was obtained before surgery from all patients and parents, respectively. Testicular biopsies were performed under general anesthesia. After cutting along the scrotal raphe, the tunica albuginea was opened. The testicular tissue was incised, three small biopsies were taken and transferred to 32 ml medium (Gibco™ Leibovitz's L-15 (11415-049, Invitrogen, Carlsbad, CA, USA)); 10% human serum albumin (9988, Irvine Scientific, Santa Ana, CA, USA); 1% penicillin/streptomycin (15140122, Invitrogen); 1% minimum essential medium non-essential amino acids (11140-035, Invitrogen). One of the three tissue samples was fixed in Bouin's solution and embedded in paraffin for histological evaluation. Two tissue samples were prepared for testicular tissue cryopreservation. Testicular volumes were determined using a Prader orchidometer and/or by ultrasound, as described previously (Behre et al., 1989 A total of 39 human samples from the patient cohort were divided into three subgroups: Patients suffering from diseases that do not directly affect the testes (NT); patients suffering from diseases that directly affect the testes (AT), and Klinefelter patients (KS). Testicular volumes were determined for one side by sonography. When sonography was not available, testicular volumes determined by Prader orchidometer are indicated (*).
Materials and Methods

Ethical approval
Histological and immunohistological evaluation of human testicular tissue
For histological analyses, tissue fragments were fixed overnight in Bouin's solution and washed with 70% ethanol. The tissues were routinely embedded in paraffin using an automatic ethanol and paraffin row (Bavimed Laborgeräte GmbH, Birkenau, Germany). Tissue sections of 3 μm thickness were prepared. Sections of each tissue sample were stained with periodic acid-Schiff's reagent/Mayer's hematoxylin.
Immunohistochemical stainings were performed according to published protocols (Albert et al., 2012) . Briefly, sections were deparaffinized and rinsed with tap water. For antigen retrieval, tissue sections were heated in citrate buffer (pH 6; 0.1 M C 6 H 8 O 7 · H 2 O, 0.1 M C 6 H 5 Na 3 O 7 · H 2 O, Aqua dest.) in a microwave oven at 85°C for 13 min. Endogenous peroxidases were inactivated by applying H 2 O 2 (3%) and nonspecific binding sites were blocked by application of TBS containing 25% chicken serum and 0.5% bovine serum albumin for 30 min. Subsequently, human testicular tissue sections were incubated in a humid chamber overnight at 4°C with the monoclonal mouse-anti-MAGEA4 (MAGE Family Member A4) antibody (kindly provided as a gift by Prof. G.C. Spagnoli from the University Hospital of Basel, Switzerland; 1:20) in blocking medium. The following day, sections were incubated with respective secondary antibodies (chicken-anti-rabbit IgG-Biotin, sc-2986, Santa Cruz Biotechnology, Santa Cruz, CA, USA (1:100)) for 1 h at room temperature. Streptavidin conjugated with horse-radish peroxidase (S5512, Sigma) (1:500) was added to the sections and incubated for 45 min at room temperature. For visualization of MAGEA4 positive cells 3,3′-Diaminobenzidine was employed. Counterstains were performed using Mayer's hematoxylin (1.09249.0500, Merck-Millipore, Darmstadt, Germany). After dehydration in an increasing ethanol series, MAGEA4 stained slides were mounted with Merckoglas. For each staining, negative controls, which were incubated with the respective control isotypes, were included.
Testicular tissue composition, quantification of germ cells and most advanced germ cell type employing morphometric approaches Point counting analyses were employed to assess testicular tissue composition of patient samples. Pictures were taken using an Olympus BX61 microscope (Melville, NY, USA) with an attached Retiga 400 R camera (QImaging, Burnaby, BC, Canada). Images were taken at ×20 magnification from two independent tissue sections (at least 15 μm apart) in a systematic randomized, investigator-blinded approach. Pictures were then transferred to a Power Point slide with a grid of 50 randomly distributed points. For all testicular tissue sections, every fifth point was assigned to one of the following categories: tubules with germ cells; tubules without germ cells; degenerated tubules; interstitium. For those tissue sections of sufficient size, 25 images were evaluated resulting in a total of 250 points per section and 500 points per sample. Data are presented as the relative proportion in tissue fragments, as a percentage.
Quantitative morphometric analysis was performed to assess the absolute number of germ cells per mm 3 for all patients. Images of MAGEA4 stained sections were taken at ×40 magnification. For each patient two independent sections were evaluated completely. Pictures were analyzed using ImageJ (National Institutes of Health, MD, USA) and the corresponding cell counter plugin. All MAGEA4 positive and negative gonocytes, spermatogonia and spermatocytes within the section were counted. The investigator was blinded to the samples. Gonocytes, spermatogonia and spermatocytes were identified based on their size and location. Characteristic for gonocytes was their localization in the center of seminiferous cords, whereas spermatogonia were located at the basal membrane. Spermatocytes undergoing meiosis were identified based on their characteristic size and nuclear morphology. Measurement of nuclear size of 20 cells for the respective cell types revealed a mean diameter of 6.49 ± 1.11 μm for gonocytes, 5.89 ± 0.81 μm for spermatogonia and 7.99 ± 1.28 μm for spermatocytes. The area of each cross section was measured using ViewPoint (PreciPoint GmbH, Freising, Germany). The area of the patient sections ranged from 2.54 to 26.48 mm 2 . Germ cell numbers per mm 3 were calculated using the equation previously published (Gundersen and Jensen, 1985; Wreford, 1995) : ; V testis = mm 3 ;
V v nuc,testis = number of germ cells multiplied by the mean nuclear volume of the respective germ cell type divided by the volume of the histological section (area in mm 2 × 3 μm); and V N = mean nuclear volume.
Statistical analyses
The main components of testicular tissue are given as a percentage and were thus analyzed using the non-parametric Kruskal-Wallis test to compare multiple samples followed by a post-hoc procedure. Germ cell numbers were analyzed by ANOVA and post-hoc least significant difference test. Significant difference is marked with * for P < 0.05, ** for P < 0.01 and *** for P < 0.001. Hence, normalizations and tests for normality were not necessary in these cases. Otherwise, data are shown as single dots, and means and SDs are also given. Data passed the normality tests according to Shapiro-Wilk and were not transformed. We used SPSS 24.0, (IBM, Chicago, IL, USA). No outliers were excluded.
Results
To date 39 prepubertal and pubertal patients have stored testicular tissues as a fertility reserve at our center. Tissue composition was assessed and quantification of germ cell types was performed (Fig. 1A) . Based on these results, we propose a diagnostic germ cell score, which includes the spermatogonial numbers and differentiation status of individual tissues (Fig. 1B) .
Developmental parameters of the patient cohort
The 39 patients were a heterogeneous group in terms of diagnoses and previous treatment, leading to their assignment to three groups. In group 1 testicular tissues were unaffected by disease or previous treatment (NT group; n = 6; diagnoses included Hodgkin's lymphoma, osteosarcoma or sarcoma). In group 2 patients were included in whom testicular tissues were potentially affected by disease or treatment (AT group; n = 14, diagnoses included thalassemia, sickle cell anemia, testicular tumor or chemotherapy prior to tissue retrieval). Group 3 consisted of patients with KS (KS group; n = 19) ( Table I) . Testicular volume was found to correlate with age in the patient cohort, but no significant differences were observed among the three groups (Table I) .
Composition of testicular tissues
To assess the testicular tissue composition of the three groups, the relative proportions of seminiferous tubules with and without germ cells, degenerated tubules and interstitium were determined ( Fig. 2A) .
Testicular tissues of the NT group predominantly consisted of tubules with germ cells and interstitium (Fig. 2B) . Tissue composition was different in the AT and KS patients ( Fig. 2C and D) . Specifically, in testicular tissues of KS patients the interstitium accounted for the largest proportion of the tissue (64.9 ± 11.6%) whereas the proportion of tubules with germ cells was significantly reduced to 2.5 ± 4.1% (P < 0.05).
Germ cell numbers and differentiation status as basis for a proposed diagnostic germ cell score to assess the fertility preservation potential of testicular tissues
As different germ cell types are present in immature testicular tissues, the numbers of gonocytes, spermatogonia and spermatocytes were determined following MAGEA4 staining, and considering MAGEA4 positive as well as negative cells (Fig. 3A) . As spermatogonia are the target cells for experimental approaches to fertility preservation, we here focused on their absolute numbers per mm (Fig. 3B ). In the AT and KS groups spermatogonial numbers were lower compared to the NT group ( Fig. 3C and D) , reaching statistical significance for the Klinefelter group (P < 0.001). Also in the AT and KS groups, spermatogonial numbers showed a high inter-individual variability.
To assess the influence of ageing on the numbers of spermatogonia, data were plotted according to age. Within the NT group, the 6-year-old patient (n = 1) showed the lowest number of spermatogonia (63.1 spermatogonia per mm 3 (×10 3 )) whereas remaining patients aged 11-14 years (n = 5) had spermatogonia in the range of 88.0-134.1 per mm 3 (×10 3 ). Yet, among these patients we did not observe a general increase of spermatogonial numbers with age ( Fig. 4A) . Analyzing the testicular tissue characteristics of the patients, we defined a germ cell score based on the abundance of spermatogonia and the germ cell differentiation status. For absolute numbers the lower 95th CI in tissues from NT patients was determined, serving as a lower threshold (75.4 spermatogonia per mm 3 (x10 3 )). Tissues above this value were assigned to category 2, below this threshold to category 1 and tissues without germ cells to category 0 (Fig. 4A ). Concerning germ cell differentiation, four categories were sufficient to describe clearly the different developmental stages: gonocytes and spermatogonia; spermatogonia; spermatogonia and spermatocytes; gonocytes, spermatogonia and spermatocytes (Fig. 4B, a-d) . Based on these two parameters personalized germ cell scores were assigned to all patient samples ( Fig. 4C-E) . For example, a score of 2a (NT2) means that undifferentiated germ cells are present in the patient's testis and spermatogonial numbers are within the normal range, whereas a score of 1c (AT8) stands for a patient with differentiating germ cells up to the meiotic stage and with spermatogonial values below the 95th Cl. Interestingly, individual patients with a mixed pattern of germ cell differentiation were detected in all three patient groups and were of various ages (NT4, AT6, AT14, KS3; age range: 10-17 years). 
Discussion
We found evidence that a patient's individual score is of enormous importance as the patients were highly variable with regard to developmental stage, disease, treatment and, in particular, integrity of testicular tissues. Thus, we aimed at identifying robust and valid parameters for the assessment of patients' immature testicular tissues stored for fertility preservation and performed a detailed analysis of germ cell presence and differentiation combining them into a diagnostic germ cell score. Importantly, neither the differentiation status nor the presence of spermatogonia was predictable (i.e. based on age, testicular volume or hormone values) as prepubertal development is highly variable among individuals. For example, KS patients without germ cells and KS patients with germ cells had similar testicular volumes. Furthermore, the use of methods such as the Johnsen score or progress of maturation as the leading parameter is excluded here as it can be only applied to adult tissues focusing only on the presence of sperm (Johnsen, 1970; de Michele et al., 2016) . Such findings are therefore of no direct relevance to immature testicular tissues.
Regarding spermatogonial numbers, individualized evaluation is essential due to the high inter-individual differences ranging from no spermatogonia at all to more than 10 5 spermatogonia per volume unit.
In particular, we observed a high tissue heterogeneity in the AT patient group. One explanation for this is that the AT group includes patients with different diseases and, in some cases, previous treatments. Interindividual differences were also observed in the KS patient group. Testicular tissues showed, if at all, focal spermatogenesis, which is corroborated by previous studies (Wistuba et al., 2017) . As a consequence of this, we cannot exclude that, even though we did not observe germ cells in 12 out of 19 tissues, residual germ cells might be present in another piece of the cryopreserved testicular tissue. Importantly, we detected residual spermatogonia in three patients aged 12-13 years and also in three patients aged 19-20 years. Within this age range, the germ cell loss in Klinefelter patients appears to be rather independent of age. In line with this, Rohayem et al. (2015) reported that absolute numbers of germ cells were generally decreased but spermatogonia persisted also in individual young men with KS. Relative proportions of these categories were determined in two independent testicular tissue sections for the NT group (n = 6, B), the AT group (n = 14, C) and the KS group (n = 19, D). Scale bars = 20 μm. Graphs show mean ± SD. Data were analyzed by non-parametric KruskalWallis test. Significant differences are depicted as *P < 0.05; **P < 0.01; ***P < 0.001.: AT = affected testes; DT = degenerated tubule; Int = interstitial tissue; KS = Klinefelter syndrome; NT = not affected testes; w GC = tubule with germ cells; w/o GC = tubule without germ cells.
The general effect of age on spermatogonial numbers has been reported previously. In a comprehensive study, testicular tissues from 50 boys aged 0-18 years have been analyzed (Müller and Skakkebaek, 1983) . Analyses suggest an increasing numerical density of germ cells with age. Specifically, the following numbers were reported for the respective age groups: 5-61 × 10 3 /mm 3 (1-4.9 years of age), 14-60 × 10 3 /mm 3 (5-9.9 years of age), 32-64 × 10 3 /mm 3 (10-13.9) and 56-131 × 10 3 /mm 3 (14-17.9 years). The high inter-individual variability is supported by the range of germ cell numbers within, and the overlap between, the different age groups. More recently, a systematic review and meta-analysis was performed to unveil the age-related quantity of spermatogonia in prepubertal testes (Masliukaite et al., 2016) . Based on data obtained from 334 boys, spermatogonial density per cm 3 appears to decrease slightly until 3 years of age, followed by a slight increase until 7 years. Spermatogonial density remains stable until the age of 10 years and then increases considerably (Masliukaite et al., 2016) . Our data are generally in agreement with these datasets, even though the agerange within the NT group needs to be increased in the future for a more robust comparison.
Irrespective of patient age though, data from experimental studies suggested that the information on spermatogonial numbers and differentiation status of starting material will be highly valuable. Experimental approaches currently under development for fertility restoration include germ cell transplantation, xenografting and organ culture. Germ cell transplantation of 27.7 × 10 6 adult murine testicular cells resulted in the formation of only 234 SSCs colonies in recipient testes (Nagano, 2003; Ogawa et al., 2003) . What is more, a study employing non-human primates for germ cell autotransplantation also provided information on the yield of sperm counts. Hermann et al. collected 45.6 × 10 6 viable testicular cells from juvenile monkeys for autotransplantation. Animals then underwent busulfan treatment, resulting in endogenous germ cell depletion. Subsequent autotransplantation of testicular cells resulted in the re-establishment of spermatogenesis and total mean sperm counts of 16 × 10 6 per ejaculate after puberty (Hermann et al., 2012) . Whereas one entire testis was used for this approach in the primate study, much less material is available for human studies, i.e. 20-30 mg of testicular tissue is cryopreserved in the frame of the fertility preservation network Androprotect. We determined that 30 mg of testicular tissue would contain 0.02-4.42 × 10 6 spermatogonia for patients with the lowest (AT4) and highest (NT2) numbers of spermatogonia, respectively. It is important to note that protocols for the dissociation of human testicular tissues are associated with high cell loss. Enzymatic digestion of adult testicular tissues with qualitatively intact spermatogenesis resulted only in 36 × 10 4 living testicular cells (Schneider et al., 2015) .
These data indicate that protocols of enzymatic digestion need to be further improved to obtain the highest possible cell numbers and protocols need to be developed which enable the propagation of human SSCs in vitro.
Compared to the approach of germ cell transplantation, which requires a single cell suspension as starting material, in vitro spermatogenesis and tissue grafting have the benefit that three-dimensional testicular tissue is maintained. Despite this fact, in vitro spermatogenesis employing an organ culture approach and healthy immature mouse testicular tissues as starting material only led to development of elongated spermatids in 17.4% of seminiferous tubules after 30 days of culture. Efficiencies of round spermatid production were even lower using rat as a model (4.1%) (Supplementary Table SI provides overview of efficiencies in approaches to fertility preservation) (Dumont et al., 2015; Reda et al., 2016) . To date, even grafting of testicular tissue pieces has resulted in only low efficiencies, although this approach provides a better supply of tissues with nutrients and hormones. In particular, autologous grafting of testicular tissue fragments from rhesus monkeys (30-49 months old, n = 5) (Jahnukainen et al., 2006 (Jahnukainen et al., , 2012 or marmoset monkeys (1 month, n = 5) (Luetjens et al., 2008) into the scrotum did result in germ cell maturation and the formation of sperm. However, in the rhesus monkeys this approach was only successful in 1/5 animals and only in two out of 60 grafts. Even in those two grafts, only 13-17% of tubules contained sperm. In the marmosets, grafting was successful in all animals but only 12.4% elongating spermatids were found (Jahnukainen et al., 2006 (Jahnukainen et al., , 2012 Luetjens et al., 2008) . Available data therefore indicate that high amounts of human testicular tissue will be required for approaches of in vitro spermatogenesis or tissue grafting. Human testicular tissues collected in the frame of Androprotect (20-30 mg) correspond to~15-40 biopsy fragments. As the datasets on germ cell transplantation, in vitro spermatogenesis and grafting yielded relatively low efficiencies despite the use of intact testicular tissues, it appears highly likely that those human testicular tissues with normal spermatogonial numbers will have higher chances of success (once these experimental protocols have been further optimized) compared to tissue samples with low spermatogonial numbers. However, the final proof that patients with a high score have better chances to benefit from the stored tissues can only be obtained once relevant protocols are available.
Additionally, it appears highly likely that immature testicular tissues (score: a) will need different culture conditions compared to more mature testicular tissues (scores: b, c). This assumption is corroborated by data from Sato et al. who have shown that efficiencies of in vitro spermatogenesis using adult (full spermatogenesis) and pup testicular tissues (only spermatogonia) are different, despite identical media conditions. Pup testicular tissues cultures performed significantly better, as the percentage of tubules containing differentiating germ cells was 49.6% whereas in adult tissues only 15.2% of the tubules contained differentiating germ cells (Sato et al., 2015) .
As both spermatogonial numbers and the differentiation status of testicular tissues will have an effect on the success of fertility preservation techniques, we developed a germ cell score which allows the assessment of these parameters in a valid and standardized manner. Such assessment is necessary for three reasons. First, due to a high variability of the patients' testicular tissues individual assessment of the tissues is essential. Second, an individual score will be a prerequisite for validation of future fertility preservation, inducing differentiation of spermatogonia into sperm. Immature testicular tissues will need different culture conditions compared to more mature testicular tissues. Third, a standardized assessment is essential for clinical counseling strategies regarding the potential of the preserved tissues for future fertility. Such a standardized evaluation of cryopreserved tissues is of major relevance because some centers are already considering starting re-transplantation of cryopreserved tissues. Our scoring system will support an objective interpretation and enhance the comparability of results obtained from different centers worldwide.
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